Phönix 3
Phönix 3, licence 02232172: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Bona Dea Limited
- NPN or DIN-HM
- 02232172
- Status
- Inactive licence
- Licence date
- 15 April 2008
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
- Conditions légales
Juniperus communis L.: L'étiquetage doit comporter un avertissement recommandant de ne pas utiliser en cas d'insuffisance rénale et un avertissement recommandant de ne pas utiliser de manière prolongée (maximum 6 semaines)
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Urtica urens L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Solidago virgaurea Source : Inflorescences | 1.0 D | Not calculated |
| Zincum metallicum Source : Zinc | 8.0 D | Not calculated |
| Camphre Source : d-Camphre | 2.0 D | Not calculated |
| Juniperus communis e fructibus siccatis Source : Baie(s) | 1.0 D | Not calculated |
| Helleborus viridis Source : Racine | 4.0 D | Not calculated |
| Cuprum sulphuricum Source : Sulfate de cuivre (II) pentahydraté | 4.0 D | Not calculated |
| Urtica urens Source : Plante(s) entière | 2.0 D | Not calculated |
Non-medicinal ingredients
Éthanol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 20.0 Goutte(s) | 3.0 Tous les jours |
Uses authorised in Canada
Homeopathic Medicine
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Do not use on children under the age of 12. Do not use if you are pregnant or breastfeeding. To be used on the advice of a health care practitioner. Consult a health care practitioner if symptoms persist or worsen.
Source
Official Health Canada record, licence 02232172
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.